Dynamic evolution of COVID‐19 vaccine hesitancy over 2021–2023 among Chinese population: Repeated nationwide cross‐sectional study

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Repeated cross-sectional study reveals rising COVID-19 vaccine hesitancy in Chinese adults, highlighting the need for targeted immunization policies.

Vaccine hesitancy increased substantially across China between 2021 and 2023, driven by chronic conditions, urban residency, and low developer trust.
Hesitation rates rose from 8.39% in 2021 to 29.72% in 2023 across nationwide cohorts, while displaying a positive correlation with long covid.
Repeated cross-sectional study surveys applied the 3cs model and eah model across three phases, highlighting determinants for future vaccination programs.

Shen et al. (2024) studied this question.

View Full Paper

Ask AI

Bookmark

Repeated cross-sectional study reveals rising COVID-19 vaccine hesitancy in Chinese adults, highlighting the need for targeted immunization policies.